4.5 Article

The role of muscle biopsy in the age of genetic testing

Journal

CURRENT OPINION IN NEUROLOGY
Volume 22, Issue 5, Pages 543-553

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WCO.0b013e32832ffc60

Keywords

molecular genetic testing; muscle biopsy; muscular dystrophy; myopathology; myopathy

Funding

  1. Talecris Biotherapeutics Limited (Canada)

Ask authors/readers for more resources

Purpose of review The purpose of this review is to discuss the role of muscle biopsy in the current age of genetic testing. Recent findings The diagnostic approach to patients with suspected genetically determined myopathies has been altered by recent advances in molecular diagnostic technologies and by the increased number of conditions for which the genetic alterations have been identified. Myopathological aspects can narrow down the differential diagnosis when the clinical phenotype is not informative enough and can help guide the molecular investigation. Summary Here, we review genetic and myopathological aspects of selected genetically determined myopathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available